Mingyue Sheng, Mingyue Sheng, Xun Chen, Xun Chen, Yan Yu, Yan Yu, . . . Gangling Chen. (2023). Rev-erbα agonist SR9009 protects against cerebral ischemic injury through mechanisms involving Nrf2 pathway. Frontiers Media S.A..
Chicago Style (17th ed.) CitationMingyue Sheng, et al. Rev-erbα Agonist SR9009 Protects Against Cerebral Ischemic Injury Through Mechanisms Involving Nrf2 Pathway. Frontiers Media S.A., 2023.
MLA (9th ed.) CitationMingyue Sheng, et al. Rev-erbα Agonist SR9009 Protects Against Cerebral Ischemic Injury Through Mechanisms Involving Nrf2 Pathway. Frontiers Media S.A., 2023.
Warning: These citations may not always be 100% accurate.